Surprise provision in $1.9 trillion Democratic aid plan shows ‘pharmaceutical sector faces risk,’ analysts say
February 19, 2021 at 11:46 AM EST
The draft legislation for Democrats’ big COVID-19 relief package features a provision that could hurt some drug makers, as it aims to increase the amount paid in rebates by companies selling into Medicaid.
